Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace

Zivo Bioscience began trading on the OTCID marketplace effective May 11, 2026, a move the company says aligns with its need for streamlined reporting and operational flexibility. The transition allows the company to maintain public trading and shareholder liquidity within a disclosure framework suited to its current growth stage. CEO John B.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.